• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cox-2、Survivin 和 Bcl-2 在肝细胞癌(HCC)中的表达的临床意义。

Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).

机构信息

Department of Medical Oncology, Cancer Center of West China Hospital, Sichuan University, Chengdu, China.

出版信息

Med Oncol. 2011 Sep;28(3):796-803. doi: 10.1007/s12032-010-9519-y. Epub 2010 Apr 17.

DOI:10.1007/s12032-010-9519-y
PMID:20401641
Abstract

Cox-2, Survivin and Bcl-2 are frequently overexpressed in numerous types of cancers. They are known to be the important regulators of apoptosis. This study was designed to investigate the correlation between the clinical characteristics and the expression of Cox-2, Survivin and Bcl-2 in hepatocellular carcinoma. A total of 63 postoperative hepatocellular carcinoma (HCC) samples, 10 adjacent non-tumor samples and 10 normal liver samples were immunochemically detected for the expression of Cox-2, Survivin and Bcl-2. A median follow-up of 4 years for the 63 HCC patients was conducted. Univariate tests and multivariate Cox regression were performed for statistical analysis. The Kaplan-Meier method was used to analyze the survival. Positive expression of Cox-2 (84.3%) and Survivin (77.8%) was detected significantly more frequently in the HCC samples than in the normal liver tissues (30% and 0, respectively). Bcl-2 was highly expressed in the adjacent non-tumor tissue. Cox-2 was positively correlative to Survivin. Survivin and Bcl-2 were significantly associated with the pathological grade of HCC (P<0.05). Expression of both Cox-2 and Survivin was significantly associated with the poor overall survival (OS) (P=0.0141, P=0.0039). Furthermore, multivariate analysis confirmed the independent prognostic value of Survivin expression, along with tumor size and hepatic function. Cox-2 and Survivin were highly expressed in the HCC tissue. Survivin and Bcl-2 were significantly associated with the pathological grade of HCC. The expression of Survivin was an independent prognostic factor for HCC after a hepatectomy. Treatment that inhibits Survivin may be a promising targeted approach in HCC.

摘要

Cox-2、Survivin 和 Bcl-2 在多种癌症中常过度表达,它们被认为是细胞凋亡的重要调节因子。本研究旨在探讨 Cox-2、Survivin 和 Bcl-2 在肝癌中的表达与临床特征的相关性。采用免疫组化法检测 63 例肝癌术后组织、10 例癌旁非肿瘤组织和 10 例正常肝组织中 Cox-2、Survivin 和 Bcl-2 的表达情况,对 63 例肝癌患者进行了 4 年的中位随访。对所有数据进行单因素和多因素 Cox 回归分析。Kaplan-Meier 法用于分析生存情况。结果显示,肝癌组织中 Cox-2(84.3%)和 Survivin(77.8%)的阳性表达率明显高于正常肝组织(分别为 30%和 0),Bcl-2 在癌旁非肿瘤组织中高表达。Cox-2 与 Survivin 呈正相关。Survivin 和 Bcl-2 与肝癌的病理分级显著相关(P<0.05)。Cox-2 和 Survivin 的表达与患者的总生存(OS)显著相关(P=0.0141,P=0.0039)。多因素分析证实,Survivin 的表达与肿瘤大小和肝功能一起是独立的预后因素。Cox-2 和 Survivin 在肝癌组织中高表达,Survivin 和 Bcl-2 与肝癌的病理分级显著相关。Survivin 的表达是肝癌患者肝切除术后的独立预后因素。抑制 Survivin 的治疗可能是肝癌有前途的靶向治疗方法。

相似文献

1
Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).Cox-2、Survivin 和 Bcl-2 在肝细胞癌(HCC)中的表达的临床意义。
Med Oncol. 2011 Sep;28(3):796-803. doi: 10.1007/s12032-010-9519-y. Epub 2010 Apr 17.
2
The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.自噬基因beclin-1在肝细胞癌中的表达及其与临床病理和预后的相关性。
BMC Cancer. 2014 May 9;14:327. doi: 10.1186/1471-2407-14-327.
3
Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.USP22和Survivin的表达是肝细胞癌恶性行为的一个指标。
Int J Oncol. 2015 Dec;47(6):2208-16. doi: 10.3892/ijo.2015.3214. Epub 2015 Oct 20.
4
Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival.生存素在肝细胞癌中的表达。与临床病理特征及总生存期的相关性。
J BUON. 2019 Sep-Oct;24(5):1934-1942.
5
TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.TLR3 表达与肝细胞癌中的细胞凋亡、增殖和血管生成相关,并可预测预后。
BMC Cancer. 2015 Apr 9;15:245. doi: 10.1186/s12885-015-1262-5.
6
Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.SOX9 的表达特征与肝癌的肿瘤进展和不良预后相关。
Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.
7
Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.眼无同源盒1的过表达预示肝细胞癌预后不良。
Int J Clin Exp Pathol. 2014 May 15;7(6):3018-27. eCollection 2014.
8
Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.神经胶质抗原2在肝细胞癌中的过表达预示预后不良。
World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.
9
Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma.Sprouty 2 蛋白表达在人肝细胞癌中的预后意义及其临床相关性。
Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):177-84. doi: 10.1016/s1499-3872(12)60145-3.
10
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.一种在肝细胞癌中上调的新型预后生物标志物SPC24。
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.

引用本文的文献

1
A potential gateway to understanding liver disease development: peripartum lipid fluctuations in dairy cows.理解肝脏疾病发展的一个潜在切入点:奶牛围产期的脂质波动
Front Cell Dev Biol. 2024 Nov 26;12:1370717. doi: 10.3389/fcell.2024.1370717. eCollection 2024.
2
Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma.依维莫司与长春瑞滨协同作用抑制肝癌生长。
Int J Mol Sci. 2023 Dec 19;25(1):17. doi: 10.3390/ijms25010017.
3
Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors.

本文引用的文献

1
Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.环氧化酶-2过表达是早期高分化肝细胞癌的一个特征,预后良好。
J Clin Pathol. 2009 Aug;62(8):690-3. doi: 10.1136/jcp.2009.065888.
2
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.舒尼替尼单药治疗晚期肝细胞癌的疗效、安全性及潜在生物标志物:一项II期研究
J Clin Oncol. 2009 Jun 20;27(18):3027-35. doi: 10.1200/JCO.2008.20.9908. Epub 2009 May 26.
3
Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
系统生物学网络揭示了11号染色体q臂缺失的儿童神经母细胞瘤肿瘤中COX-2表达与7号染色体q臂拷贝数改变之间的相关性。
Genes Cancer. 2022 Dec 2;13:60-71. doi: 10.18632/genesandcancer.225. eCollection 2022.
4
Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers.溶血磷脂酸信号传导与微小RNA:在多种癌症中的新作用
Front Oncol. 2022 Jun 23;12:917471. doi: 10.3389/fonc.2022.917471. eCollection 2022.
5
Fluorescence imaging of hepatocellular carcinoma with a specific probe of COX-2.使用COX-2特异性探针进行肝细胞癌的荧光成像。
RSC Adv. 2018 Jan 3;8(2):994-1000. doi: 10.1039/c7ra07819f. eCollection 2018 Jan 2.
6
Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma.大黄代谢产物诱导细胞凋亡:肝细胞癌潜在机制综述
Front Pharmacol. 2022 Mar 2;13:806175. doi: 10.3389/fphar.2022.806175. eCollection 2022.
7
Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway.丹皮酚通过环氧化酶-2/前列腺素E2信号通路,经由生存素诱导肝癌细胞产生抗肿瘤效应。
Transl Cancer Res. 2020 Nov;9(11):7183-7195. doi: 10.21037/tcr-20-322A.
8
Snail Upregulates Transcription of FN, LEF, COX2, and COL1A1 in Hepatocellular Carcinoma: A General Model Established for Snail to Transactivate Mesenchymal Genes.蜗牛上调肝细胞癌中 FN、LEF、COX2 和 COL1A1 的转录:建立了蜗牛转激活间充质基因的一般模型。
Cells. 2021 Aug 26;10(9):2202. doi: 10.3390/cells10092202.
9
Interplay between cyclooxygenase‑2 and microRNAs in cancer (Review).环氧化酶-2 与 microRNAs 在癌症中的相互作用(综述)。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.11986. Epub 2021 Mar 24.
10
Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer.环氧化酶-2抑制剂:癌症免疫治疗的一种潜在联合策略
Front Oncol. 2021 Feb 26;11:637504. doi: 10.3389/fonc.2021.637504. eCollection 2021.
索拉非尼治疗肝细胞癌:区分炒作与希望。
J Clin Oncol. 2008 Dec 20;26(36):5845-8. doi: 10.1200/JCO.2008.19.7996. Epub 2008 Nov 24.
4
The prognostic significance of COX-2 and survivin expression in ovarian cancer.COX-2和生存素表达在卵巢癌中的预后意义。
Pathol Res Pract. 2008;204(4):241-9. doi: 10.1016/j.prp.2007.11.004. Epub 2008 Jan 2.
5
Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis.病毒性肝炎患者血清中bcl-2水平及细胞氧化应激情况
Indian J Med Microbiol. 2007 Oct;25(4):323-9. doi: 10.4103/0255-0857.37333.
6
Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level.乳腺癌中Bcl-2的表达:mRNA和蛋白质水平的比较研究
Anticancer Res. 2007 Jan-Feb;27(1A):219-22.
7
Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy.生存素与颗粒酶B诱导的细胞凋亡,一种新型抗癌疗法。
Mol Cancer Ther. 2006 Mar;5(3):693-703. doi: 10.1158/1535-7163.MCT-05-0423.
8
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence.生存素在原位和浸润性乳腺癌中的表达与环氧化酶-2表达及导管原位癌复发相关。
Br J Cancer. 2006 Jan 30;94(2):253-8. doi: 10.1038/sj.bjc.6602932.
9
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1.存活素在乳腺癌中的表达可预测临床结果,并与HER2、血管内皮生长因子、尿激酶型纤溶酶原激活剂及纤溶酶原激活物抑制因子1相关。
Ann Oncol. 2006 Apr;17(4):597-604. doi: 10.1093/annonc/mdj121. Epub 2006 Jan 10.
10
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.环氧化酶-2过表达与壶腹癌切除患者的不良预后相关。
Clin Cancer Res. 2005 May 15;11(10):3784-9. doi: 10.1158/1078-0432.CCR-04-2136.